FLURAZEPAM HYDROCHLORIDE

FLURAZEPAM HYDROCHLORIDE was reported 406 times

FLURAZEPAM HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUSCLE RELAXANT DRUG LEVEL ABOVE THERAPEUTIC 2 0.2500
1 CONGENITAL SPINAL FUSION 1 0.0385
2 STIFF TONGUE 3 0.0370
3 CHRONIC PIGMENTED PURPURA 4 0.0205
4 KLEPTOMANIA 1 0.0137
5 DIAPHRAGMATIC INJURY 1 0.0135
6 FLUOROSIS 1 0.0116
7 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 3 0.0116
8 SINONASAL OBSTRUCTION 4 0.0100
9 FOETAL MOVEMENTS DECREASED 1 0.0098
10 TRAUMATIC SHOCK 1 0.0087
11 BENIGN NEOPLASM OF BLADDER 1 0.0084
12 URINARY BLADDER POLYP 2 0.0073
13 SINUS POLYP 4 0.0069
14 CREATINE KINASE INCREASED 5 0.0065
15 HEMIVERTEBRA 1 0.0059
16 INTERCOSTAL NEURALGIA 1 0.0056
17 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
18 PECTUS EXCAVATUM 1 0.0049
19 REBOUND PSYCHOSIS 1 0.0047
20 ULTRASOUND ANTENATAL SCREEN ABNORMAL 1 0.0045
21 TRAUMATIC LIVER INJURY 1 0.0043
22 NASAL INJURY 3 0.0042
23 PHARMACEUTICAL NOMADISM 2 0.0039
24 SOPOR 51 0.0038
25 REPETITIVE SPEECH 2 0.0036
26 FLASHBACK 2 0.0035
27 ASPIRATION BRONCHIAL 1 0.0034
28 APRAXIA 5 0.0034
29 PCO2 DECREASED 3 0.0031
30 CHEST WALL PAIN 1 0.0030
31 BRADYPNOEA 8 0.0030
32 PAINFUL ERECTION 2 0.0029
33 PTERYGIUM 1 0.0029
34 LARYNGEAL DISORDER 2 0.0028
35 CLAUSTROPHOBIA 3 0.0027
36 ALCOHOL POISONING 7 0.0026
37 PO2 DECREASED 3 0.0026
38 DEPENDENCE ON RESPIRATOR 1 0.0025
39 DELUSIONAL DISORDER, PERSECUTORY TYPE 1 0.0024
40 ADENOMA BENIGN 2 0.0023
41 AMNESTIC DISORDER 1 0.0021
42 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
43 INTENTIONAL SELF-INJURY 40 0.0020
44 PO2 INCREASED 1 0.0020
45 SELF INJURIOUS BEHAVIOUR 6 0.0020
46 VISCERAL CONGESTION 1 0.0020
47 ABDOMINAL INJURY 1 0.0019
48 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
49 MULTIPLE DRUG OVERDOSE INTENTIONAL 6 0.0019
50 EXECUTIVE DYSFUNCTION 1 0.0018
51 ADRENAL HAEMORRHAGE 1 0.0018
52 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
53 COMA SCALE ABNORMAL 5 0.0017
54 SUBSTANCE ABUSE 14 0.0017
55 BLADDER OPERATION 2 0.0017
56 DROP ATTACKS 1 0.0017
57 DERMO-HYPODERMITIS 1 0.0017
58 PLASMA CELL LEUKAEMIA 1 0.0017
59 SLOW SPEECH 4 0.0016
60 STUPOR 5 0.0016
61 SKIN ABRASION 7 0.0015
62 PCO2 INCREASED 1 0.0014
63 BRONCHIAL WALL THICKENING 1 0.0014
64 BRADYPHRENIA 9 0.0014
65 ABDOMINAL HERNIA 6 0.0013
66 THYROID MASS 5 0.0013
67 LIMB MALFORMATION 1 0.0013
68 LONG QT SYNDROME 3 0.0013
69 EROSIVE DUODENITIS 1 0.0013
70 OCULAR VASCULAR DISORDER 1 0.0012
71 FOETAL DISORDER 1 0.0012
72 SPINAL DEFORMITY 2 0.0012
73 PATHOLOGICAL FRACTURE 6 0.0012
74 BLADDER NEOPLASM 2 0.0012
75 TETANY 2 0.0011
76 SKIN OEDEMA 1 0.0010
77 AKINESIA 2 0.0010
78 INFUSION SITE DISCOMFORT 1 0.0010
79 MYOPATHY 8 0.0009
80 SUICIDE ATTEMPT 55 0.0009
81 PUPILS UNEQUAL 1 0.0009
82 HYPOCHLORAEMIA 1 0.0009
83 HYPORESPONSIVE TO STIMULI 1 0.0009
84 SUBCUTANEOUS ABSCESS 4 0.0008
85 VENTRICULAR ARRHYTHMIA 3 0.0008
86 DRUG ABUSE 68 0.0008
87 HYPOMANIA 3 0.0008
88 RECTAL TENESMUS 1 0.0008
89 CALCIUM DEFICIENCY 1 0.0008
90 FAECES HARD 3 0.0008
91 SOMNAMBULISM 5 0.0008
92 CEREBRAL ATROPHY 3 0.0008
93 HYPERLACTACIDAEMIA 2 0.0007
94 ENURESIS 3 0.0007
95 ECCHYMOSIS 5 0.0007
96 INFUSION SITE RASH 1 0.0007
97 INTENTIONAL OVERDOSE 46 0.0007
98 ENDOTRACHEAL INTUBATION 2 0.0007
99 APPENDIX DISORDER 1 0.0007
100 MULTIPLE CONGENITAL ABNORMALITIES 1 0.0007
101 HYPOGLYCAEMIC COMA 2 0.0007
102 BILIARY DILATATION 1 0.0007
103 BRADYKINESIA 4 0.0007
104 GASTRITIS HAEMORRHAGIC 1 0.0007
105 MIXED LIVER INJURY 2 0.0007
106 INGUINAL HERNIA 4 0.0007
107 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
108 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
109 RESPIRATORY RATE DECREASED 2 0.0006
110 INHIBITORY DRUG INTERACTION 1 0.0006
111 ANTICHOLINERGIC SYNDROME 1 0.0006
112 TINEA PEDIS 1 0.0006
113 ENTERITIS 4 0.0006
114 PARKINSONISM 6 0.0006
115 INTESTINAL POLYP 1 0.0006
116 MULTIPLE DRUG OVERDOSE 3 0.0006
117 POTENTIATING DRUG INTERACTION 2 0.0006
118 DEAFNESS BILATERAL 1 0.0006
119 BLOOD PH DECREASED 1 0.0006
120 BLOOD CHLORIDE INCREASED 1 0.0006
121 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
122 COMA 26 0.0005
123 OESOPHAGEAL SPASM 1 0.0005
124 ALCOHOL USE 2 0.0005
125 BLOOD BICARBONATE DECREASED 1 0.0005
126 GUN SHOT WOUND 1 0.0005
127 SPUTUM DISCOLOURED 5 0.0005
128 FACE INJURY 2 0.0005
129 CONVERSION DISORDER 1 0.0005
130 CELL DEATH 1 0.0005
131 SLUGGISHNESS 5 0.0005
132 HYPERPHOSPHATAEMIA 1 0.0005
133 INFUSION SITE BRUISING 1 0.0005
134 REACTION TO DRUG EXCIPIENTS 1 0.0005
135 DYSPHEMIA 2 0.0005
136 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
137 RETROPERITONEAL HAEMATOMA 1 0.0005
138 FAECES PALE 1 0.0004
139 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
140 BRONCHITIS CHRONIC 1 0.0004
141 POISONING 5 0.0004
142 EMPHYSEMA 4 0.0004
143 DIABETIC COMPLICATION 1 0.0004
144 SEDATION COMPLICATION 1 0.0004
145 EUPHORIC MOOD 4 0.0004
146 HIATUS HERNIA 5 0.0004
147 VENTRICULAR DYSFUNCTION 1 0.0004
148 RADICULOPATHY 1 0.0004
149 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
150 MIOSIS 3 0.0004
151 DECREASED ACTIVITY 4 0.0004
152 LIP BLISTER 1 0.0004
153 THYROID NEOPLASM 1 0.0004
154 PSYCHOMOTOR RETARDATION 1 0.0004
155 PNEUMATOSIS INTESTINALIS 1 0.0004
156 HAEMOTHORAX 1 0.0003
157 SEXUAL DYSFUNCTION 4 0.0003
158 MUSCLE RIGIDITY 4 0.0003
159 PROSTATITIS 1 0.0003
160 PHARYNGITIS 4 0.0003
161 EOSINOPHILIC PNEUMONIA 1 0.0003
162 BLOOD URINE PRESENT 6 0.0003
163 HEAD INJURY 10 0.0003
164 MYDRIASIS 4 0.0003
165 POSTURE ABNORMAL 1 0.0003
166 DEAFNESS NEUROSENSORY 1 0.0003
167 VERTIGO 18 0.0003
168 TOXICITY TO VARIOUS AGENTS 49 0.0003
169 TYPE I HYPERSENSITIVITY 1 0.0003
170 JAUNDICE CHOLESTATIC 1 0.0003
171 APPENDICECTOMY 1 0.0003
172 GASTROENTERITIS 4 0.0003
173 CHRONIC SINUSITIS 1 0.0003
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
175 ACIDOSIS 2 0.0003
176 OESOPHAGEAL ULCER 1 0.0003
177 COGNITIVE DISORDER 12 0.0003
178 APNOEA 2 0.0003
179 RESPIRATORY ACIDOSIS 1 0.0003
180 POLYDIPSIA 1 0.0003
181 DISORIENTATION 10 0.0003
182 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
183 GALLBLADDER OPERATION 1 0.0002
184 RIB FRACTURE 5 0.0002
185 ACUTE CORONARY SYNDROME 2 0.0002
186 HALLUCINATIONS, MIXED 1 0.0002
187 HALLUCINATION, VISUAL 5 0.0002
188 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
189 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
190 INTERVERTEBRAL DISC DISORDER 1 0.0002
191 MUSCULOSKELETAL DISCOMFORT 4 0.0002
192 SPEECH DISORDER 12 0.0002
193 INTENTIONAL DEVICE MISUSE 1 0.0002
194 PHYSICAL DISABILITY 1 0.0002
195 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
196 AKATHISIA 3 0.0002
197 MIDDLE INSOMNIA 4 0.0002
198 FAECAL INCONTINENCE 1 0.0002
199 HUMERUS FRACTURE 1 0.0002
200 SINUS BRADYCARDIA 2 0.0002
201 DYSSTASIA 6 0.0002
202 HYPERNATRAEMIA 1 0.0002
203 VARICOSE VEIN 1 0.0002
204 SEDATION 5 0.0002
205 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
206 BEHAVIOUR DISORDER 1 0.0002
207 SKIN LACERATION 2 0.0002
208 HYDROCEPHALUS 1 0.0002
209 FAECALOMA 1 0.0002
210 ON AND OFF PHENOMENON 1 0.0002
211 MENTAL STATUS CHANGES 5 0.0002
212 URINARY RETENTION 6 0.0002
213 BLOOD CALCIUM DECREASED 2 0.0002
214 DRUG INTERACTION 28 0.0002
215 GRANULOCYTOPENIA 1 0.0002
216 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
217 VISUAL DISTURBANCE 1 0.0002
218 SOMNOLENCE 35 0.0002
219 RHABDOMYOLYSIS 7 0.0002
220 POLYNEUROPATHY 2 0.0002
221 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
222 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
223 SCHIZOPHRENIA 2 0.0002
224 PRESYNCOPE 4 0.0002
225 RESPIRATORY DEPRESSION 2 0.0002
226 DRUG ABUSER 1 0.0002
227 SCOLIOSIS 1 0.0002
228 BLEPHAROSPASM 1 0.0002
229 BRAIN OEDEMA 2 0.0002
230 SLEEP APNOEA SYNDROME 3 0.0002
231 HEPATITIS ACUTE 1 0.0002
232 ANGINA UNSTABLE 1 0.0002
233 DEAFNESS 4 0.0002
234 PULMONARY CONGESTION 2 0.0002
235 CHOLECYSTITIS CHRONIC 1 0.0001
236 BRONCHIECTASIS 1 0.0001
237 DISTURBANCE IN ATTENTION 8 0.0001
238 WRONG PRODUCT ADMINISTERED 1 0.0001
239 DRUG TOXICITY 2 0.0001
240 TACHYCARDIA 13 0.0001
241 DIVERTICULITIS 4 0.0001
242 FORMICATION 1 0.0001
243 SINUS TACHYCARDIA 2 0.0001
244 ANGINA PECTORIS 4 0.0001
245 HYPOKINESIA 2 0.0001
246 HYDRONEPHROSIS 1 0.0001
247 DYSARTHRIA 5 0.0001
248 PEMPHIGOID 1 0.0001
249 HAEMODYNAMIC INSTABILITY 1 0.0001
250 HYPERTHERMIA 1 0.0001
251 CONFUSIONAL STATE 21 0.0001
252 TREATMENT NONCOMPLIANCE 7 0.0001
253 TORSADE DE POINTES 1 0.0001
254 DRUG SCREEN POSITIVE 1 0.0001
255 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
256 PRODUCTIVE COUGH 6 0.0001
257 ATRIAL FLUTTER 1 0.0001
258 LOSS OF CONSCIOUSNESS 16 0.0001
259 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
260 RESPIRATORY FAILURE 9 0.0001
261 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
262 EXTRAPYRAMIDAL DISORDER 3 0.0001
263 MUSCLE INJURY 1 0.0001
264 INFUSION SITE ERYTHEMA 1 0.0001
265 FACE OEDEMA 2 0.0001
266 HYSTERECTOMY 1 0.0001
267 MENTAL DISORDER 5 0.0001
268 ORTHOSTATIC HYPOTENSION 2 0.0001
269 ANHEDONIA 3 0.0001
270 FEAR 3 0.0001
271 TINNITUS 5 0.0001
272 INCREASED TENDENCY TO BRUISE 1 0.0001
273 UROSEPSIS 1 0.0001
274 IRON DEFICIENCY ANAEMIA 1 0.0001
275 COMPLETED SUICIDE 9 0.0001
276 BLOOD CREATININE INCREASED 7 0.0001
277 APPENDICITIS 1 0.0001
278 ABORTION INDUCED 1 0.0001
279 SPINAL DISORDER 1 0.0001
280 HYPOTENSION 21 0.0001
281 INFLAMMATORY BOWEL DISEASE 1 0.0001
282 BODY TEMPERATURE DECREASED 1 0.0001
283 LIGAMENT SPRAIN 1 0.0001
284 HYPOTONIA 1 0.0001
285 SALIVARY HYPERSECRETION 1 0.0001
286 ASTHMA 11 0.0001
287 HYPERBILIRUBINAEMIA 1 0.0001
288 SCRATCH 1 0.0001
289 SUDDEN DEATH 1 0.0001
290 BODY HEIGHT DECREASED 1 0.0001
291 BIPOLAR DISORDER 1 0.0001
292 GASTROINTESTINAL PAIN 1 0.0001
293 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
294 MALNUTRITION 1 0.0001
295 OCULAR DISCOMFORT 1 0.0001
296 IMPAIRED DRIVING ABILITY 1 0.0001
297 PRODUCT AVAILABILITY ISSUE 2 0.0001
298 GASTRIC HAEMORRHAGE 1 0.0001
299 NIGHTMARE 3 0.0001
300 HYPOKALAEMIA 4 0.0001
301 EYELID OEDEMA 1 0.0001
302 COVID-19 PNEUMONIA 1 0.0001
303 WHEEZING 5 0.0001
304 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
305 BLOOD IRON DECREASED 1 0.0001
306 THYROID CANCER 1 0.0001
307 ILL-DEFINED DISORDER 5 0.0001
308 RESTLESSNESS 3 0.0001
309 CEREBRAL INFARCTION 2 0.0001
310 DYSURIA 3 0.0001
311 ENCEPHALOPATHY 2 0.0001
312 FALL 27 0.0001
313 GENERALISED OEDEMA 1 0.0001
314 PNEUMONIA ASPIRATION 2 0.0001
315 INTENTIONAL PRODUCT MISUSE 7 0.0001
316 DERMATITIS ALLERGIC 1 0.0001
317 INFUSION SITE PAIN 1 0.0001
318 UNRESPONSIVE TO STIMULI 2 0.0001
319 DIPLOPIA 2 0.0001
320 RESPIRATORY TRACT INFECTION 2 0.0001
321 TOOTH INFECTION 1 0.0001
322 ACUTE HEPATIC FAILURE 1 0.0001
323 VISION BLURRED 10 0.0001
324 HYPOMAGNESAEMIA 1 0.0001
325 MYELODYSPLASTIC SYNDROME 1 0.0001
326 ANOSMIA 1 0.0001
327 LIVER FUNCTION TEST ABNORMAL 2 0.0001
328 CARDIOMYOPATHY 1 0.0001
329 INSOMNIA 18 0.0001
330 PULMONARY MASS 1 0.0001
331 TREMOR 11 0.0001
332 OSTEOPENIA 1 0.0001
333 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
334 SUICIDAL IDEATION 6 0.0001
335 OVERDOSE 14 0.0001
336 THYROID DISORDER 1 0.0001
337 CHEST PAIN 12 0.0001
338 GYNAECOMASTIA 2 0.0001
339 DECREASED APPETITE 15 0.0001
340 LUNG INFECTION 1 0.0001
341 PRODUCT USE COMPLAINT 1 0.0001
342 PNEUMOTHORAX 1 0.0001
343 ULCER 1 0.0001
344 AMNESIA 4 0.0001
345 DRUG LEVEL INCREASED 1 0.0001
346 FEBRILE NEUTROPENIA 4 0.0001
347 SYNCOPE 6 0.0001
348 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
349 HAEMOGLOBIN DECREASED 6 0.0001
350 SCAR 1 0.0001
351 DELIRIUM 2 0.0001
352 NERVOUSNESS 3 0.0001
353 EOSINOPHILIA 1 0.0001
354 COLD SWEAT 1 0.0001
355 BRADYCARDIA 3 0.0001
356 TOOTHACHE 1 0.0001
357 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
358 PANIC ATTACK 2 0.0001
359 CONJUNCTIVITIS 1 0.0001
360 HEPATIC FUNCTION ABNORMAL 2 0.0001
361 DYSPNOEA EXERTIONAL 2 0.0001
362 HYPOCALCAEMIA 1 0.0001
363 DEPRESSION 12 0.0001
364 DYSPHAGIA 5 0.0001
365 DEHYDRATION 7 0.0001
366 INCREASED APPETITE 1 0.0001
367 GLAUCOMA 1 0.0001
368 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
369 PRESCRIBED OVERDOSE 1 0.0001
370 MEMORY IMPAIRMENT 7 0.0001
371 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
372 HAEMATOCRIT DECREASED 1 0.0001
373 CATARACT 3 0.0001
374 BLOOD PRESSURE ABNORMAL 1 0.0001
375 PRESCRIBED UNDERDOSE 1 0.0001
376 DRY MOUTH 4 0.0000
377 OSTEOPOROSIS 2 0.0000
378 ASTHENIA 18 0.0000
379 CARDIO-RESPIRATORY ARREST 2 0.0000
380 EATING DISORDER 1 0.0000
381 RETCHING 1 0.0000
382 IMPAIRED WORK ABILITY 1 0.0000
383 POOR QUALITY SLEEP 1 0.0000
384 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
385 PRODUCT PRESCRIBING ISSUE 1 0.0000
386 STEVENS-JOHNSON SYNDROME 1 0.0000
387 RASH MACULO-PAPULAR 1 0.0000
388 INFLUENZA 5 0.0000
389 PULMONARY OEDEMA 2 0.0000
390 SKIN DISCOLOURATION 2 0.0000
391 PERICARDIAL EFFUSION 1 0.0000
392 MULTIPLE SCLEROSIS 2 0.0000
393 BLOOD PRESSURE FLUCTUATION 1 0.0000
394 CONTUSION 4 0.0000
395 HYPOGLYCAEMIA 2 0.0000
396 NEURALGIA 1 0.0000
397 URINARY TRACT INFECTION 7 0.0000
398 AGITATION 3 0.0000
399 ABASIA 1 0.0000
400 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
401 AGGRESSION 2 0.0000
402 HALLUCINATION 3 0.0000
403 FLUID RETENTION 2 0.0000
404 HEPATITIS 1 0.0000
405 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
406 ILLNESS 4 0.0000
407 SKIN ULCER 1 0.0000
408 HAEMATOMA 1 0.0000
409 MUSCULOSKELETAL PAIN 2 0.0000
410 JOINT STIFFNESS 1 0.0000
411 THROAT TIGHTNESS 1 0.0000
412 MOOD ALTERED 1 0.0000
413 RESPIRATORY DISTRESS 1 0.0000
414 ABNORMAL DREAMS 1 0.0000
415 NECK PAIN 2 0.0000
416 PANCYTOPENIA 2 0.0000
417 WEIGHT INCREASED 8 0.0000
418 OXYGEN SATURATION DECREASED 2 0.0000
419 HYPONATRAEMIA 2 0.0000
420 TARDIVE DYSKINESIA 1 0.0000
421 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
422 CONVULSION 2 0.0000
423 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
424 INFECTION 5 0.0000
425 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
426 ACUTE MYOCARDIAL INFARCTION 1 0.0000
427 BLOOD POTASSIUM DECREASED 1 0.0000
428 OEDEMA PERIPHERAL 4 0.0000
429 EPILEPSY 1 0.0000
430 FEMUR FRACTURE 1 0.0000
431 NERVOUS SYSTEM DISORDER 1 0.0000
432 METABOLIC ACIDOSIS 1 0.0000
433 NIGHT SWEATS 1 0.0000
434 INCORRECT DOSE ADMINISTERED 7 0.0000
435 CHOLELITHIASIS 1 0.0000
436 HEART RATE INCREASED 3 0.0000
437 BACK PAIN 7 0.0000
438 SKIN DISORDER 1 0.0000
439 MALAISE 13 0.0000
440 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
441 SINUSITIS 3 0.0000
442 PYREXIA 10 0.0000
443 BURNING SENSATION 2 0.0000
444 HYPERKALAEMIA 1 0.0000
445 COVID-19 5 0.0000
446 DYSPNOEA 16 0.0000
447 CEREBRAL HAEMORRHAGE 1 0.0000
448 PNEUMONIA 9 0.0000
449 C-REACTIVE PROTEIN INCREASED 1 0.0000
450 HYPERGLYCAEMIA 1 0.0000
451 ACCIDENTAL OVERDOSE 1 0.0000
452 THROMBOCYTOPENIA 3 0.0000
453 BLOOD PRESSURE INCREASED 4 0.0000
454 GAIT DISTURBANCE 5 0.0000
455 VOMITING 12 0.0000
456 HEADACHE 16 0.0000
457 PARAESTHESIA 4 0.0000
458 DISEASE PROGRESSION 3 0.0000
459 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
460 DYSKINESIA 1 0.0000
461 BLINDNESS 1 0.0000
462 LUNG NEOPLASM MALIGNANT 1 0.0000
463 ABDOMINAL PAIN UPPER 5 0.0000
464 CARDIAC ARREST 2 0.0000
465 VISUAL IMPAIRMENT 3 0.0000
466 NAUSEA 19 0.0000
467 WITHDRAWAL SYNDROME 1 0.0000
468 HYPERTENSION 5 0.0000
469 OSTEOARTHRITIS 1 0.0000
470 RENAL FAILURE ACUTE 1 0.0000
471 HYPERHIDROSIS 3 0.0000
472 HYPOACUSIS 1 0.0000
473 MUSCULOSKELETAL STIFFNESS 2 0.0000
474 ADVERSE DRUG REACTION 2 0.0000
475 NEPHROLITHIASIS 1 0.0000
476 RENAL DISORDER 1 0.0000
477 BLOOD CHOLESTEROL INCREASED 1 0.0000
478 ARRHYTHMIA 1 0.0000
479 PULMONARY EMBOLISM 2 0.0000
480 DISEASE RECURRENCE 1 0.0000
481 ATRIAL FIBRILLATION 2 0.0000
482 LUNG DISORDER 1 0.0000
483 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
484 INFLAMMATION 1 0.0000
485 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
486 ABDOMINAL DISTENSION 2 0.0000
487 ECZEMA 1 0.0000
488 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
489 DRUG EFFECT DECREASED 1 0.0000
490 RASH PRURITIC 1 0.0000
491 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
492 HAEMATOCHEZIA 1 0.0000
493 MEDICATION ERROR 1 0.0000
494 SEPSIS 2 0.0000
495 PAIN 11 0.0000
496 MUSCULAR WEAKNESS 2 0.0000
497 ABDOMINAL PAIN 4 0.0000
498 DYSPHONIA 1 0.0000
499 BLADDER CANCER 1 0.0000
500 PAIN IN EXTREMITY 5 0.0000
501 FEELING ABNORMAL 4 0.0000
502 NO ADVERSE EVENT 3 0.0000
503 THERAPEUTIC RESPONSE DECREASED 1 0.0000
504 STOMATITIS 1 0.0000
505 DISCOMFORT 1 0.0000
506 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
507 RHINORRHOEA 1 0.0000
508 DEEP VEIN THROMBOSIS 1 0.0000
509 BLOOD PRESSURE DECREASED 1 0.0000
510 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
511 INJECTION SITE REACTION 1 0.0000
512 ARTHRALGIA 6 0.0000
513 COUGH 4 0.0000
514 INJURY 1 0.0000
515 SLEEP DISORDER 1 0.0000
516 FATIGUE 11 0.0000
517 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
518 ANXIETY 4 0.0000
519 DIZZINESS 7 0.0000
520 MOBILITY DECREASED 1 0.0000
521 DYSGEUSIA 1 0.0000
522 HYPOAESTHESIA 2 0.0000
523 HOT FLUSH 1 0.0000
524 UNEVALUABLE EVENT 1 0.0000
525 DIABETES MELLITUS 1 0.0000
526 INJECTION SITE SWELLING 1 0.0000
527 PRURITUS 5 0.0000
528 DRUG DEPENDENCE 2 0.0000
529 THROMBOSIS 1 0.0000
530 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
531 RENAL IMPAIRMENT 1 0.0000
532 SKIN EXFOLIATION 1 0.0000
533 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
534 DRUG WITHDRAWAL SYNDROME 1 0.0000
535 DEVICE ISSUE 1 0.0000
536 ADVERSE EVENT 1 0.0000
537 BREAST CANCER 1 0.0000
538 PRODUCT USE ISSUE 2 0.0000
539 DRUG INEFFECTIVE 14 0.0000
540 BLOOD GLUCOSE INCREASED 2 0.0000
541 ANAEMIA 2 0.0000
542 DRUG INTOLERANCE 1 0.0000
543 OFF LABEL USE 9 0.0000
544 HAEMORRHAGE 1 0.0000
545 RASH 4 0.0000
546 SEIZURE 1 0.0000
547 PALPITATIONS 1 0.0000
548 CHILLS 1 0.0000
549 JOINT SWELLING 1 0.0000
550 EMOTIONAL DISTRESS 1 0.0000
551 DEATH 7 0.0000
552 DIARRHOEA 5 0.0000
553 NEUTROPENIA 1 0.0000
554 WEIGHT DECREASED 2 0.0000
555 ACUTE KIDNEY INJURY 1 0.0000
556 PERIPHERAL SWELLING 1 0.0000
557 ABDOMINAL DISCOMFORT 1 0.0000
558 MYALGIA 1 0.0000
559 MYOCARDIAL INFARCTION 1 0.0000
560 MUSCLE SPASMS 1 0.0000
561 NASOPHARYNGITIS 1 0.0000
562 HYPERSENSITIVITY 1 0.0000
563 ERYTHEMA 1 0.0000
564 PRODUCT DOSE OMISSION ISSUE 1 0.0000
565 CONDITION AGGRAVATED 1 0.0000
566 INJECTION SITE PAIN 1 0.0000